Cancer is the second-leading cause of death in the U.S., annually killing more than 590,000 Americans. Soon it could eclipse heart disease.

TGen is using advanced technology to explore the human genome, discovering the origins of cancer — especially lung, colon, pancreas, blood, breast and brain cancers and those affecting children — developing methods of early detection, and turning life-threatening diseases into merely chronic conditions that allow patients not only to live, but thrive.

TGen's precision medicine explorations bring better treatments to more patients. They take discoveries in the lab and translate them into treatment quickly and effectively. To do this requires being able to manipulate massive quantities of data — moving it to where it needs to be, managing it securely and processing it intelligently.

The analytical challenge of working with a data set of that size requires intelligent systems that can incorporate AI and machine learning. By automating baseline data interrogation, humans are free to focus on the finer points of what it all means.

TGen's partnership with Dell Technologies to handle all these complexities results in better outcomes for researchers and patients alike.

From Alzheimer's to ALS — from concussions and other traumatic brain injuries to stroke — TGen's Neurogenomics Division seeks answer to both common and rare neurological disorders.

TGen's Center for Noninvasive Diagnostics looks for early warning signs of medical conditions, while TGen's Center for Rare Childhood Disorders is diagnosing pediatric ailments at nearly three times the national average.

Participate in TGen research — take the MindCrowd memory test

When TGen’s founder, Arizona-born Dr. Jeffrey Trent, was the Scientific Director of the National Human Genome Research Institute at the National Institutes of Health, Senator McCain was instrumental in convincing him to return to Arizona and bring new knowledge with him, establishing TGen in an effort to turn breakthroughs in genetic research into medical advances. Today, TGen is poised to take that knowledge and transform brain cancer research in honor of Senator John McCain.

Learn More

The Translational Genomics Research Institute is focused on developing early diagnostics and treatments, which help to improve the lives of people like Shelby, by unraveling the human genetic sequence and innovating molecular medicine techniques.